Daily Cosmetic Research Analysis
Key advances today span cosmetic safety, equity, and environmental health. Spatial metabolomics maps multi-organ toxicity of a widely used cosmetic ingredient (borneol), literature analysis reveals persistent underrepresentation of darker skin types in cosmetic dermatology research, and environmental monitoring identifies leachable UV stabilizers in single-use plastics used for personal care packaging.
Summary
Key advances today span cosmetic safety, equity, and environmental health. Spatial metabolomics maps multi-organ toxicity of a widely used cosmetic ingredient (borneol), literature analysis reveals persistent underrepresentation of darker skin types in cosmetic dermatology research, and environmental monitoring identifies leachable UV stabilizers in single-use plastics used for personal care packaging.
Research Themes
- Cosmetic ingredient safety and toxicology
- Equity and representation in cosmetic dermatology
- Environmental exposures from personal care packaging
Selected Articles
1. Spatial metabolomics revealed multi-organ toxicity and visualize metabolite changes induced by borneol in zebrafish.
Using zebrafish and MALDI-MSI spatial metabolomics, the study shows that high-dose borneol induces multi-organ toxicity (cardiac, hepatic, neurologic) and broad metabolic dysregulation without evident renal toxicity. Perturbations in phospholipids, fatty acids, and amino acids and transcriptional changes in lipid/choline/amino acid metabolism pathways suggest mechanism-based safety concerns for borneol used in cosmetics and medicines.
Impact: Introduces spatial metabolomics to map organ-specific toxicity of a widely used cosmetic/pharmaceutical excipient, providing mechanistic evidence that can inform safety thresholds and regulatory evaluation.
Clinical Implications: While preclinical, the data support cautious use of borneol in topical and inhalational products and motivate dose-limit justification, alternative excipient consideration, and targeted safety testing (e.g., cardiotoxicity and neurobehavioral assays) in product development.
Key Findings
- High-concentration borneol (500 μM) caused morphological abnormalities, cardiotoxicity, hepatotoxicity, and neurotoxicity in zebrafish, with no evident renal toxicity.
- MALDI-MSI revealed significant increases in PC-34:1/34:2, PI-36:4, PE-36:1, LysoPE-22:5, LysoPC-18:1, FA-18:2, phenylalanine, lysine, and glutathione, and decreases in PC-38:6 and PC-40:6.
- mRNA levels of genes involved in phospholipid, fatty acid, choline, and amino acid metabolism (e.g., elovl5, chpt1, chka, setd7, hgd) were significantly altered.
Methodological Strengths
- Integration of spatial metabolomics (MALDI-MSI) with multi-organ phenotyping in vivo
- Mechanistic readouts linking metabolite shifts to transcriptional changes in key metabolic pathways
Limitations
- High exposure concentration relative to likely human cosmetic exposure; external validity uncertain
- Zebrafish model lacks human pharmacokinetic and dermal penetration data; no dose–response across lower concentrations reported
Future Directions: Quantify human-relevant exposure ranges, perform dermal exposure models and dose–response studies, and integrate in vitro human cardiomyocyte/neuronal assays to refine risk assessment.
This study focuses on the potential hazards of borneol (BO) to aquatic organisms and human health. BO has antibacterial, anti-inflammatory and antioxidant activities, and is widely used in medicine, cosmetics, and detergents. In this study, zebrafish was used as a model organism to systematically evaluate the effects of BO on the heart, liver, kidney, and nervous system. The effects of BO on metabolites of zebrafish were studied using MALDI-MSI. The results showed that a high concentration of BO (500 μM) could induce morphological abnormalities (swim-bladder loss, spinal curvature, body-length shortening), cardiotoxicity (decreased heart rate, increased SV-BA distance), hepatotoxicity (reduced liver area index), and neurotoxicity (impaired behavioral ability, and dopamine neuron development deficits), but there was no renal toxicity observed in zebrafish. Additionally, MALDI-MSI analysis showed that BO exposure significantly altered the levels of metabolites, including phospholipids, fatty acids, choline, and amino acids. The contents of PC-34:1, PC-34:2, PI-36:4, PE-36:1, LysoPE-22:5, LysoPC-18:1, FA-18:2, phenylalanine, lysine and glutathione were significantly increased, while the contents of PC-38:6 and PC-40:6 were significantly decreased. Notably, BO elicited a significant alteration in the mRNA expression levels of genes associated with phospholipid metabolism, fatty acid metabolism, choline metabolism, and amino acid metabolism (such as elovl5, chpt1, chka, setd7, hgd). This study revealed that BO exerted toxicity on multiple organs and demonstrated that BO causes metabolic dysregulation in zebrafish. These findings provide a novel insight into the toxicity of BO.
2. Non-essential use of benzotriazole ultraviolet stabilizers in single-use plastics manufactured in India: An avoidable class of plastic additives.
Six benzotriazole UV stabilizers were quantified in plastic debris from Indian water bodies, with highest loads in food-contact materials and detectable UV-329 in personal care product sachets. Leaching studies indicate these additives can mobilize into water and pose low-to-moderate ecological risk, questioning the necessity of BUVs in short-lived consumer packaging.
Impact: Provides original quantitative evidence of leachable UV stabilizers in single-use plastics, including personal care packaging, informing environmental and public health policy and safer packaging design.
Clinical Implications: Although indirect, findings support reducing BUVs in consumer packaging, encouraging dermatology/cosmetic stakeholders to prefer BUV-free or low-leach alternatives and to consider environmental safety in product stewardship.
Key Findings
- Highest BUV concentrations were found in food-contact materials, with UV-P, UV-327, UV-326, and UV-328 predominant in HDPE debris.
- UV-329 was the predominant stabilizer detected in personal care product sachets; UV-320 was not detected.
- Leaching experiments show BUVs can mobilize into surrounding water and pose low-to-moderate ecological risk (RQ ≥ 0.1) to plankton.
Methodological Strengths
- Analytical quantification across multiple BUVs with material categorization and polymer type consideration
- Leaching experiments and ecological risk quotient estimation link measurements to potential environmental impact
Limitations
- Sampling of environmental debris may not represent all manufactured products or regions
- No direct human exposure or toxicokinetic assessment; limited number of personal care packaging types
Future Directions: Expand to targeted market sampling of unopened products, assess human exposure pathways, evaluate alternatives to BUVs, and integrate life cycle and policy analyses for substitution.
Benzotriazole ultraviolet stabilizers (BUVs) are extensively utilized as additives in various polymeric formulations to protect against harmful UV radiation. Classified as persistent, mobile, and toxic additives, BUVs have attracted the attention of researchers and regulatory bodies worldwide. However, there is limited information on the BUVs content in different plastics. This study investigated the presence of six major BUVs in plastic debris collected from Indian water bodies. Based on the usage, plastic debris was categorized into food contact materials (FCMs), personal care products (PCPs), and household items. Plastic debris made of high-density polyethylene had the highest concentrations of UV-P, followed by UV-327, UV-326, and UV-328. UV-329 was the predominant UV stabilizer detected in the PCP sachet, while UV-320 was not detected in any of the plastic debris analyzed. Leaching experiments showed that plastic debris could serve as a mobile source of BUVs to the surrounding water and pose a low to moderate ecological risk (RQ ≥ 0.1) to planktons. The content of UV stabilizer was highest in FCMs (mean ± SD: 27787.98 ± 2304.14 ng/g), compared to PCPs (mean ± SD: 9115.49 ± 2891.18 ng/g) and household items (mean ± SD: 3215.03 ± 521.92 ng/g). The occurrence of BUVs in short-lived plastics such as FCMs, PCPs sachets and daily household items raises human health concerns, questioning the necessity of adding BUVs in these plastics.
3. Skin of color representation in cosmetic dermatology literature, 2018-2023.
Screening 5,175 cosmetic dermatology articles (2018–2023) identified only 561 focused on Skin of Color, and just 214 reported Fitzpatrick skin type. Representation skewed toward FST III/IV and East Asian populations, highlighting underrepresentation of darker skin types and the need for standardized ethnicity/FST reporting and inclusive research.
Impact: Provides a quantitative baseline of representation gaps in cosmetic dermatology, directly informing reporting standards, journal policies, and equitable research agendas.
Clinical Implications: Clinicians should be cautious when extrapolating cosmetic outcomes from FST III/IV studies to FST V/VI patients; journals and investigators should mandate standardized ethnicity and FST reporting and prioritize recruitment of underrepresented groups.
Key Findings
- Out of 5,175 screened articles, 561 (10.84%) met inclusion for SOC focus; only 214 (4.14%) reported Fitzpatrick skin type.
- Representation was biased toward FST III (40.74%) and IV (40.53%), and East Asian (57.75%) and MENA (24.06%) populations.
- Most research originated from East Asia (56.15%); many SOC articles lacked specific FST details and focused on hair issues.
Methodological Strengths
- Large-scale screening across five cosmetic dermatology journals with predefined inclusion criteria
- Systematic extraction of race/ethnicity and Fitzpatrick skin type data
Limitations
- Retrospective design limited to five journals; may not capture broader literature or gray literature
- Excluding studies without race/FST may introduce selection bias; no assessment of clinical outcomes or quality
Future Directions: Develop consensus reporting standards for ethnicity and FST, expand audits to additional journals and regions, and link representation to outcomes and adverse event profiles.
Growing racial diversity raises concerns about equitable dermatology care. Only 4.5% of US medical textbooks include diverse skin types, and dermatologic literature lacks focus on Skin of Color (SOC). This study examines SOC cosmetic research in five dermatology journals. Articles from Lasers in Surgery and Medicine, Journal of Cosmetic Dermatology, Cosmetics, Lasers in Medical Science, and Clinical, Cosmetic, and Investigational Dermatology (September 2018 - September 2023) were screened for cosmetic interventions on SOC, defined as studies with > 50% non-Caucasian patients. Studies without defined race or Fitzpatrick skin type (FST) were excluded. Article type, race, ethnicity, research country, and FST were recorded. Of 5,175 screened articles, 561 (10.84%) met inclusion criteria, and 214 (4.14%) provided FST data. FST 3 (40.74%) and 4 (40.53%) were most represented. East Asian (57.75%) and Middle Eastern-North African (24.06%) ethnicities were most represented, with most research from East Asia (56.15%). SOC articles often lacked specific FST details, focusing on hair issues and came mostly from predominantly Caucasian countries. There is significant underrepresentation of SOC in cosmetic dermatology research, with bias toward FSTs 3, 4 and East Asian populations. This highlights the need for standardized ethnicity reporting and inclusive research to ensure equitable dermatologic care.